Here is some other vaccine news of note for the week:
> Altimmune CEO Bill Enright plans to step down from his post early next year, or when a successor is appointed. Washington Business Journal article
> Teams fighting the Ebola outbreak are struggling to find potential vaccine recipients. Stat News article
> Seqirus' Afluria Quadrivalent won a label expansion in the U.S. It's now approved for people 6 months and older. Release